Levothyroxine Dosage and the Increased Risk of Second Primary Malignancy in Thyroid Cancer Survivors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Levothyroxine Dosage and the Increased Risk of Second Primary Malignancy in Thyroid Cancer Survivors

Published:2024-07-01 Issue:7 Volume:36 Page:258-261
ISSN:2329-9711
Container-title:Clinical Thyroidology®
language:en
Short-container-title:Clinical Thyroidology®

Author:

Park Young Joo¹

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea; and Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/ct.2024%3B36.258-261

Reference10 articles.

1. Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study

2. Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States

3. Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer

4. Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients

5. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP